AVP BioPharma Consult ApS: Financial statements 2021
CVR: 37770426
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
AVP BioPharma Consult ApS (CVR 37770426) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 1,201,153 and a net result of DKK 260,721 compared with DKK 189,764 the year before. That is an increase of 8.5% compared with the year before. Equity in the 2021 report amounted to DKK 345,697. The solvency ratio was 66.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,201,153
- Profit/Loss
- DKK 260,721
- Equity
- DKK 345,697
- Total Assets
- DKK 516,443
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 1.2M | 261K | 346K | 1 |
| 2020 | - | 1.1M | 190K | 295K | 1 |
| 2019 | - | 1.5M | 320K | 375K | 1 |
| 2018 | - | 1M | 71K | 126K | 1 |
| 2017 | - | 1.1M | 58K | 142K | 1 |
Official annual report
Find more companies like AVP BioPharma Consult ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
AVP BioPharma Consult ApS has published its annual report for 2020. Gross profit came to DKK 1,106,641, and the net result was DKK 189,764.
About AVP BioPharma Consult ApS
AVP BioPharma Consult ApS is a Danish company of the type Anpartsselskab based in Virum, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Vagnø Pedersen. The company is owned by AVP Holdings ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,249,151 and a net result of DKK 247,464 compared with DKK 237,789 the year before. Equity in the 2025 report amounted to DKK 320,541.
